Open access · US-GOV via ClinicalTrials.gov Clinical trial

Metformin and Muscle in Insulin-resistant Older Veterans

Authors not listed

VA Office of Research and Development · 2014

Dysbiosis Metformin Human Randomized controlled trial

Abstract

Sarcopenia is the loss of muscle mass, strength and function with aging and is associated with increased disability, falls and fractures. Older adults with diabetes and prediabetes are insulin resistant and have a higher risk of developing sarcopenia. This study examines the use of metformin, an antidiabetic drug, for preventing the development of sarcopenia in older adults with prediabetes.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-22 MST

Cite this

APA

Anonymous. (2014). Metformin and Muscle in Insulin-resistant Older Veterans. <em>VA Office of Research and Development</em>. https://clinicaltrials.gov/study/NCT01804049

Vancouver

Anonymous. Metformin and Muscle in Insulin-resistant Older Veterans. VA Office of Research and Development. 2014.

BibTeX

@misc{anon2014Metfor, title = {Metformin and Muscle in Insulin-resistant Older Veterans}, author = {Anonymous}, journal = {VA Office of Research and Development}, year = {2014}, }